China · Delayed Price · Currency is CNY ChengDa Pharmaceuticals Statistics
Total Valuation
SHE:301201 has a market cap or net worth of CNY 4.62 billion. The enterprise value is 3.69 billion.
| Market Cap | 4.62B |
| Enterprise Value | 3.69B |
Important Dates
The next confirmed earnings date is Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jul 15, 2026 |
Share Statistics
SHE:301201 has 151.47 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 151.47M |
| Shares Outstanding | 151.47M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.34% |
| Owned by Insiders (%) | 40.64% |
| Owned by Institutions (%) | 2.41% |
| Float | 80.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.63 |
| PB Ratio | 2.20 |
| P/TBV Ratio | 2.24 |
| P/FCF Ratio | 645.36 |
| P/OCF Ratio | 85.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 69.47, with an EV/FCF ratio of 515.25.
| EV / Earnings | n/a |
| EV / Sales | 7.69 |
| EV / EBITDA | 69.47 |
| EV / EBIT | n/a |
| EV / FCF | 515.25 |
Financial Position
The company has a current ratio of 6.53, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.53 |
| Quick Ratio | 5.47 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.97 |
| Debt / FCF | 7.23 |
| Interest Coverage | -11.68 |
Financial Efficiency
Return on equity (ROE) is -1.06% and return on invested capital (ROIC) is -1.83%.
| Return on Equity (ROE) | -1.06% |
| Return on Assets (ROA) | -0.57% |
| Return on Invested Capital (ROIC) | -1.83% |
| Return on Capital Employed (ROCE) | -1.00% |
| Weighted Average Cost of Capital (WACC) | 3.20% |
| Revenue Per Employee | 690,793 |
| Profits Per Employee | -32,349 |
| Employee Count | 694 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 2.18 |
Taxes
| Income Tax | -1.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.72% in the last 52 weeks. The beta is -0.19, so SHE:301201's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -0.72% |
| 50-Day Moving Average | 33.48 |
| 200-Day Moving Average | 39.09 |
| Relative Strength Index (RSI) | 41.22 |
| Average Volume (20 Days) | 6,093,258 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301201 had revenue of CNY 479.41 million and -22.45 million in losses. Loss per share was -0.15.
| Revenue | 479.41M |
| Gross Profit | 132.42M |
| Operating Income | -21.58M |
| Pretax Income | -24.06M |
| Net Income | -22.45M |
| EBITDA | 53.08M |
| EBIT | -21.58M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 985.40 million in cash and 51.72 million in debt, with a net cash position of 933.68 million or 6.16 per share.
| Cash & Cash Equivalents | 985.40M |
| Total Debt | 51.72M |
| Net Cash | 933.68M |
| Net Cash Per Share | 6.16 |
| Equity (Book Value) | 2.10B |
| Book Value Per Share | 13.84 |
| Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was 53.86 million and capital expenditures -46.70 million, giving a free cash flow of 7.16 million.
| Operating Cash Flow | 53.86M |
| Capital Expenditures | -46.70M |
| Depreciation & Amortization | 74.66M |
| Net Borrowing | -36.52M |
| Free Cash Flow | 7.16M |
| FCF Per Share | 0.05 |
Margins
Gross margin is 27.62%, with operating and profit margins of -4.50% and -4.68%.
| Gross Margin | 27.62% |
| Operating Margin | -4.50% |
| Pretax Margin | -5.02% |
| Profit Margin | -4.68% |
| EBITDA Margin | 11.07% |
| EBIT Margin | -4.50% |
| FCF Margin | 1.49% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.66%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.66% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 423.33% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.61% |
| Earnings Yield | -0.49% |
| FCF Yield | 0.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jul 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
SHE:301201 has an Altman Z-Score of 14.42 and a Piotroski F-Score of 4.
| Altman Z-Score | 14.42 |
| Piotroski F-Score | 4 |